HomeArticlesToday's HighlightsBioCryst Pharmaceuticals Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema
Today's Highlights
Premium

BioCryst Pharmaceuticals Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema

BioCryst Pharmaceuticals Acquires Astria Pharmaceuticals Today, January 23, 2026, BioCryst Pharmaceuticals, Inc. ( BCRX ) announced it completed acquisition of Astria Therapeutics, Inc. , initially an...
P

Prohost Biotech

1 min read
3
0

Unlock Premium Content

This article contains exclusive content for our premium subscribers. Join our community to access in-depth research, expert insights, and comprehensive analysis.

Unlimited articles
Expert analysis
Research reports

Comments (0)

Please sign in to join the discussion